fulvestrant,alpelisib,capivasertib,elacestrant
menarini,novartis,astrazeneca,otsuka
['bcsm', 'elacestrant', 'capitello-291', ' fulv', 'alpelisib', 'breast', 'capivasertib', 'capitello,291']
we can use alpelisib in patients with pik3ca mutations or capivasertib (check out capitello-291 just published in ). single agent fulvestrant benefit is limited post cdk4/6i. elacestrant for esr1 mutations coming up in next talk! #asco23 #bcsm #breastcancer
Breast & gyn med onc @valleyhealthnj. Opinions my own. RT not endorsements. Host of INTERLUDE podcast 🎤 ASCO FCOI= https://t.co/C54erlhQe8